Mechanisms of cisplatin-induced muscle atrophy.

[1]  T. Hornberger,et al.  Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .

[2]  T. Nakagawa,et al.  5-Fluorouracil Induces Diarrhea with Changes in the Expression of Inflammatory Cytokines and Aquaporins in Mouse Intestines , 2013, PloS one.

[3]  M. Sandri,et al.  Cellular and molecular mechanisms of muscle atrophy , 2013, Disease Models & Mechanisms.

[4]  D. Guttridge,et al.  Mechanisms for maintaining muscle , 2012, Current Opinion in Supportive and Palliative Care.

[5]  D. Simone,et al.  Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy , 2012, The Journal of Neuroscience.

[6]  S. Bhatnagar,et al.  TWEAK and TRAF6 regulate skeletal muscle atrophy , 2012, Current opinion in clinical nutrition and metabolic care.

[7]  S. Bhatnagar,et al.  The E3 Ubiquitin Ligase TRAF6 Intercedes in Starvation-Induced Skeletal Muscle Atrophy through Multiple Mechanisms , 2012, Molecular and Cellular Biology.

[8]  Nirmal Singh,et al.  Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. , 2012, Toxicology.

[9]  M. Fornaro,et al.  Gαi2 Signaling Promotes Skeletal Muscle Hypertrophy, Myoblast Differentiation, and Muscle Regeneration , 2011, Science Signaling.

[10]  M. Dodd,et al.  A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients , 2011, Supportive Care in Cancer.

[11]  A. Russell,et al.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy , 2011, Pflügers Archiv - European Journal of Physiology.

[12]  D. Lacey,et al.  Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.

[13]  G. Prue,et al.  Fatigue in gynecological cancer patients during and after anticancer treatment. , 2010, Journal of pain and symptom management.

[14]  Ali Montazeri.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008 , 2009, Health and quality of life outcomes.

[15]  I. Nonaka,et al.  Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading , 2009, Molecular and Cellular Biology.

[16]  D. Beer,et al.  Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. , 2009, Neoplasia.

[17]  M. Muscaritoli,et al.  Muscle myostatin signalling is enhanced in experimental cancer cachexia , 2008, European journal of clinical investigation.

[18]  Se-Jin Lee.  Genetic Analysis of the Role of Proteolysis in the Activation of Latent Myostatin , 2008, PloS one.

[19]  Y. Itoyama,et al.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.

[20]  Donglei Zhang,et al.  Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury , 2007, Muscle & nerve.

[21]  S. Fujimoto.  Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice. , 2006, Biological & pharmaceutical bulletin.

[22]  K. Wyrwich,et al.  Assessing fatigue in persons with cancer: further validation of the Wu Cancer Fatigue Scale. , 2006, Journal of pain and symptom management.

[23]  S. Sereika,et al.  Cognitive impairment associated with adjuvant therapy in breast cancer , 2006, Psycho-oncology.

[24]  Horng-Shiuann Wu,et al.  Assessing fatigue in persons with cancer , 2004, Cancer.

[25]  J. Unützer,et al.  National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. , 2003, Journal of the National Cancer Institute.

[26]  J. Devesa,et al.  Differential Response to Exogenous and Endogenous Myostatin in Myoblasts Suggests that Myostatin Acts as an Autocrine Factor in Vivo , 2004 .

[27]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[28]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[29]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[30]  K. Yarasheski,et al.  Exercise treatment to counteract protein wasting of chronic diseases , 2003, Current opinion in clinical nutrition and metabolic care.

[31]  Carsten Helleberg,et al.  Self‐assessment in cancer patients referred to palliative care , 2002, Cancer.

[32]  D. Cella,et al.  Fatigue in cancer patients compared with fatigue in the general United States population , 2002, Cancer.

[33]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[35]  G. Lynch.  Therapies for Improving Muscle Function in Neuromuscular Disorders , 2001, Exercise and sport sciences reviews.

[36]  J. Kleeff,et al.  Overexpression of activin A in stage IV colorectal cancer , 2001, Gut.

[37]  P. Choong,et al.  Myostatin, insulin‐like growth factor‐1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy , 2001, Muscle & nerve.

[38]  B. Langley,et al.  Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation* , 2000, The Journal of Biological Chemistry.

[39]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[40]  中尾 玲子.  Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading , 2010 .

[41]  D. Glass.  PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. , 2010, Current topics in microbiology and immunology.

[42]  K. Yarasheski,et al.  Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. , 2002, The journal of nutrition, health & aging.

[43]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[44]  J. Drazen,et al.  NHLBI Workshop Summary. Models of airway hyperresponsiveness. , 1990, The American review of respiratory disease.

[45]  J. Drazen,et al.  Models of airway hyperresponsiveness , 1990 .